4.7 Article

Forearm DXA Increases the Rate of Patients With Asymptomatic Primary Hyperparathyroidism Meeting Surgical Criteria

期刊

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
卷 101, 期 7, 页码 2728-2732

出版社

ENDOCRINE SOC
DOI: 10.1210/jc.2016-1513

关键词

-

向作者/读者索取更多资源

Introduction: A reduction in bone mineral density (BMD) is common in primary hyperparathyroidism (PHPT), above all at cortical sites. Guidelines for the management of asymptomatic PHPT (aPHPT) recommend a BMD evaluation at the lumbar spine, hip, and forearm. Surgery is recommended for patients with a T-score less than or equal to -2.5 at any of these sites. However, a BMD evaluation at the forearm is not routinely performed. Aim: To evaluate the impact of measuring forearm BMD in the clinical management of aPHPT. Subjects and Methods: We retrospectively reviewed a prospective database of 172 patients with aPHPT, selecting the 116 patients in whom a dual x-ray absorptiometry (DXA) scan had been performed at all 3 sites. Results: Seventy-four out of 116 patients had a densitometric diagnosis of osteoporosis (OP) at any site, and the forearm was the only site involved in 13/74 (group A, 17.6% of osteoporotic patients and 11.2% of the whole aPHPT cohort). Patients belonging to groupAwere significantly older than the other aPHPT patients, whereas no difference was found in biochemical measurements. Six out of 13 patients belonging to group A (5.2% of the whole aPHPT cohort) fulfilled surgical criteria based only on a forearm T-score. Conclusions: DXA at 3 sites revealed OP at the forearm, but not at the other sites, in 11.2% of aPHPT patients. Half of these cases met surgical criteria based on this one factor alone. These patients did not show any clinical (except age) or biochemical differences from the other patients. The implementation of forearm DXA increases the rate of patients with aPHPT meeting surgical criteria.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective Study

Giuseppe Reimondo, Elena Castellano, Maurizio Grosso, Roberto Priotto, Soraya Puglisi, Anna Pia, Micaela Pellegrino, Giorgio Borretta, Massimo Terzolo

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Endocrinology & Metabolism

Surgical Approach to Primary Hyperparathyroidism in Patients with Concomitant Thyroid Diseases: A Retrospective Single Center Study

Elena Castellano, Paolo Benso, Roberto Attanasio, Alberto Boriano, Corrado Lauro, Giorgio Borretta, Felice Borghi

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)

Article Endocrinology & Metabolism

Parathyroid Carcinoma: An Up-to-Date Retrospective Multicentric Analysis

Francesco Quaglino, Luca Manfrino, Luca Cestino, Massimo Giusti, Enrico Mazza, Alessandro Piovesan, Nicola Palestini, Corrado Lauro, Elena Castellano

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)

Article Endocrinology & Metabolism

RADIOLOGIC MANIFESTATION OF BONE INVOLVEMENT IN PRIMARY HYPERPARATHYROIDISM: PREVALENCE AND CLINICAL SIGNIFICANCE IN A SOUTHERN EUROPEAN SERIES

Elena Castellano, Roberto Attanasio, Alberto Boriano, Valentina Borretta, Marta Gennaro, Adele Latina, Giorgio Borretta

ENDOCRINE PRACTICE (2020)

Review Endocrinology & Metabolism

Central hypogonadism in Klinefelter syndrome: report of two cases and review of the literature

Biagio Cangiano, Rita Indirli, Eriselda Profka, Elena Castellano, Giovanni Goggi, Valeria Vezzoli, Giovanna Mantovani, Maura Arosio, Luca Persani, Giorgio Borretta, Emanuele Ferrante, Marco Bonomi

Summary: This study reports two rare cases of patients with both Klinefelter syndrome and unexplained hypogonadotropic hypogonadism, characterized by incomplete puberty, low gonadotropins levels and specific clinical features. This occurrence is unusual in KS and is associated with anosmia, other hormone deficiencies, and heterogeneous karyotypes.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)

Article Endocrinology & Metabolism

Autoimmune Polyendocrine Syndrome Complicated by Pulmonary Hypertension

Olga Eugenia Disoteo, Benedetta Zampetti, Andrea Garascia, Roberto Attanasio, Renato Cozzi

Summary: A 24-year-old female with autoimmune polyendocrine syndrome type 2 presented with a variety of symptoms including acute renal failure, melanoderma, hyponatremia, hyperkalemia, heart failure, and pulmonary arterial hypertension. The treatment process requires comprehensive consideration of multiple conditions.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2021)

Article Endocrinology & Metabolism

False Positive of 68Ga-DOTATATE PET-CT in a Paraganglioma

Benedetta Zampetti, Roberto Attanasio, Marco Boniardi, Renato Cozzi

Summary: This case study describes a 75-year-old female patient diagnosed with an interaortocaval paraganglioma following the resection of a kidney tumor. Although Ga-68-DOTATATE PET-CT showed pathological uptake in the abdomen and iliac crest, it still resulted in a false-positive outcome.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2021)

Review Endocrinology & Metabolism

Diabetes and Bone Involvement in Primary Hyperparathyroidism: Literature Review and Our Personal Experience

Elena Castellano, Roberto Attanasio, Alberto Boriano, Valentina Borretta, Francesco Tassone, Giorgio Borretta

Summary: The relationship between T2DM and PHPT and their impact on bone health lacks sufficient research data, but in this study, it was found that PHPT patients with T2DM may exhibit milder symptoms in terms of bone health.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Endocrinology & Metabolism

Aldosterone Secretion in Patients With Primary Hyperparathyroidism Without Arterial Hypertension

Elena Castellano, Micaela Pellegrino, Valentina Tardivo, Roberto Attanasio, Alberto Boriano, Giorgio Borretta

Summary: The study found little correlation between PTH and RAAS in PHPT patients, even in those without hypertension. Further research is needed to explain the complex interplay between PTH and RAAS.

ENDOCRINE PRACTICE (2021)

Article Endocrinology & Metabolism

Assessment of Burnout Levels Before and During COVID-19 Pandemic: A Web-Based Survey by the (Italian) Association of Medical Endocrinolo-gists (AME)

Yura Loscalzo, Simonetta Marucci, Piernicola Garofalo, Roberto Attanasio, Giuseppe Lisco, Vincenzo De Geronimo, Edoardo Guastamacchia, Marco Giannini, Vincenzo Triggiani

Summary: The study found that during the COVID-19 pandemic, women and young physicians were more likely to experience burnout symptoms, with factors such as gender and age influencing feelings of professional accomplishment, depersonalization, and emotional exhaustion among physicians. Additionally, it was observed that burnout levels did not significantly increase for physicians not directly involved in managing COVID-19 cases compared to those who were.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2021)

Article Endocrinology & Metabolism

A Multi-professional Approach for Transition of Care at Discharge in Hyperglycemic Inpatients with COVID-19: A Single Center Study

Elena Castellano, Donatella Gaviglio, Micaela Pellegrino, Laura Gianotti, Giampaolo Magro, Francesco Tassone, Claudia Baffoni, Renza Sibbono, Roberto Attanasio, Alberto Boriano, Giorgio Borretta

Summary: The feasibility, efficacy, and safety of managing diabetes patients through telemedicine after discharge during COVID-19 have been demonstrated.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2022)

Article Endocrinology & Metabolism

A Tale of Two Hypersecreting Adrenal Neoplasms in the Heartland of COVID-19 Pandemic, Lombardy, Italy

Benedetta Zampetti, Roberto Attanasio, Emanuela Carioni, Daniela Dallabonzana, Iuliana Pauna, Marco Boniardi, Renato Cozzi

Summary: This study reports the management of two patients with Cushing's syndrome and pheochromocytoma, respectively, in Lombardy, Italy, whose surgeries were deferred due to the COVID-19 pandemic.

CASE REPORTS IN ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors

Renato Cozzi, Maria Rosaria Ambrosio, Roberto Attanasio, Claudia Battista, Alessandro Bozzao, Marco Caputo, Enrica Ciccarelli, Laura De Marinis, Ernesto De Menis, Marco Faustini Fustini, Franco Grimaldi, Andrea Lania, Giovanni Lasio, Francesco Logoluso, Marco Losa, Pietro Maffei, Davide Milani, Maurizio Poggi, Michele Zini, Laurence Katznelson, Anton Luger, Catalina Poiana

Summary: Prolactinomas are the most common pituitary adenomas and require individualized treatment approaches. Italian neuroendocrine experts have provided guidelines for diagnosis and treatment that can be easily applied in different contexts. Advances in neurosurgical endoscopic techniques have shown that surgery can result in permanent discontinuation of medication and cure for some patients.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

Use of thyroid hormones in hypothyroid and euthyroid patients: A THESIS questionnaire survey of UK endocrinologists

Younes R. Younes, Petros Perros, Laszlo Hegedus, Enrico Papini, Endre Nagy, Roberto Attanasio, Roberto Negro, Benjamin C. T. Field

Summary: The use of thyroid hormones in the management of hypothyroidism is generally in line with international guidelines among UK endocrinologists. However, a minority of respondents are willing to prescribe thyroid hormone supplementation in euthyroid individuals, despite the lack of evidence of efficacy.

CLINICAL ENDOCRINOLOGY (2023)

Article Medicine, General & Internal

Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: A THESIS questionnaire survey of members of the Irish Endocrine Society

Mohamad Mustafa, Elsheikh Ali, Anne McGowan, Laura McCabe, Laszlo Hegedues, Roberto Attanasio, Endre V. V. Nagy, Enrico Papini, Petros Perros, Carla Moran

Summary: This study investigated the attitudes of Irish endocrinologists towards the treatment of hypothyroid and euthyroid patients. The study found that LT4 tablets are the treatment of choice for hypothyroidism, but some endocrinologists may consider combination therapy or prescribing thyroid hormones to euthyroid individuals. Psychosocial factors and comorbidities were identified as the most common reasons for persistent symptoms in treated patients.

IRISH JOURNAL OF MEDICAL SCIENCE (2023)

暂无数据